Showing results (3201-3210 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Human tumor and normal tissue reactivity of the anti-(breast cancer) monoclonal antibody BA-Br-3 and its similarity to the anti-(epithelial membrane antigen) monoclonal antibody E29S K Liao, R E Flahart, B Kimbro, et al.Cancer Immunology, Immunotherapy : CII|June 13, 2026
Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trialPanpan Zhang, Ming Lu, Lijie Song, et al.Cancer Immunology, Immunotherapy : CII|June 18, 2026
A phase I study evaluating subcutaneous administration of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced solid malignanciesPiotr Rutkowski, Dariusz M Kowalski, Victor Moreno, et al.Cancer Immunology, Immunotherapy : CII|July 4, 2026
The increased co-expression of SLC7A11 and PD-L1 was associated with poor prognosis in extranodal natural killer T-cell lymphoma patientsCuiying He, Yingzhen Yao, Xiaolin Wu, et al.Cancer Immunology, Immunotherapy : CII|July 4, 2026
Macrophage heterogeneity in breast cancer microenvironment and development of a prognostic model: exploring TFF1 as a novel therapeutic targetLin Chen, Zhiqiang Chen, Bailu Shi, et al.Cancer Immunology, Immunotherapy : CII|July 4, 2026
A low-dose self-amplifying mRNA vaccine encoding HPV16 E6/E7 induces potent T-cell immunity and antitumor protection in miceRui Xing, Shanshan Wang, Yixin Wang, et al.Cancer Immunology, Immunotherapy : CII|June 29, 2026
The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapyYilin Chen, Shuaixuan Chen, Hang Zhang, et al.Cancer Immunology, Immunotherapy : CII|July 7, 2026
CXCL13-CXCR5 signaling in CD8+ T cell recruitment and lymphoid immune organization in clear cell renal cell carcinomaDaniel D Shapiro, Kye D Nichols, Moon Hee Lee, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
A survey of some formal models in tumor immunologyH F Dullens, M W Van der Tol, R A De Weger, et al.Cancer Immunology, Immunotherapy : CII|June 23, 2026
Efficacy and safety of anti-PD-1-based therapies in advanced melanoma across acral and mucosal subtypes: a nationwide retrospective cohort studyYuan Qiao, Xiao Fu, Iltaf Hussain, et al.Pageof 652